NCT01517620View on ClinicalTrials.gov

Total Glucosides Paeony Capsules in Maintaining Clinical Remission in Patients With Ankylosing Spondylitis Which Achieve Clinical Remission After Anti-TNF Therapy

PHASE4CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Ankylosing Spondylitis
Interventions
DRUG

Total Glucosides Paeony Capsules

Total Glucosides Paeony Capsules, oral, 0.3 gram per capsule, 3 capsules tid, 24 weeks

Trial Locations (2)

510630

Rheumatology Department, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou

Unknown

Rheumatology Department, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou

All Listed Sponsors
lead

Sun Yat-sen University

OTHER

NCT01517620 - Total Glucosides Paeony Capsules in Maintaining Clinical Remission in Patients With Ankylosing Spondylitis Which Achieve Clinical Remission After Anti-TNF Therapy | Biotech Hunter | Biotech Hunter